Enovis Corp Financing Receivable, Credit Loss, Expense (Reversal)
Enovis Corp (ENOV) reported Financing Receivable, Credit Loss, Expense (Reversal) of $5.48 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForLoanLossesExpensed · last filed 2026-08-06
- Enovis Corp financing receivable, credit loss, expense (reversal) for the quarter ending 2026-07-03 was $328.00K, a 66.90% decline year-over-year.
- Enovis Corp financing receivable, credit loss, expense (reversal) for the quarter ending 2026-04-03 was $5.15M, a 127.53% increase year-over-year.
- Enovis Corp financing receivable, credit loss, expense (reversal) for the quarter ending 2025-12-31 was $1.17M, a 65.59% decline year-over-year.
- Enovis Corp financing receivable, credit loss, expense (reversal) for the quarter ending 2025-10-03 was -$1.39M, a 136.07% decline year-over-year.
- Enovis Corp financing receivable, credit loss, expense (reversal) for fiscal 2025 was $3.03M, a 71.46% decline from fiscal 2024.
- Enovis Corp financing receivable, credit loss, expense (reversal) for fiscal 2024 was $10.62M.
- Enovis Corp financing receivable, credit loss, expense (reversal) for fiscal 2023 was -$4.84M, a 289.50% decline from fiscal 2022.
- Enovis Corp financing receivable, credit loss, expense (reversal) for fiscal 2022 was $2.55M, a 0.24% increase from fiscal 2021.
| Period end | Financing Receivable, Credit Loss, Expense (Reversal) 3 month | Financing Receivable, Credit Loss, Expense (Reversal) 6 month | Financing Receivable, Credit Loss, Expense (Reversal) 9 month | Financing Receivable, Credit Loss, Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2026-07-03 | $328.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.48M 10-Q · filed 2026-08-06 | $6.64M derived: sum of 3 quarters · filed 2026-08-06 | $5.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-04-03 | $5.15M 10-Q · filed 2026-05-07 | $6.32M derived: sum of 2 quarters · filed 2026-05-07 | $4.92M derived: sum of 3 quarters · filed 2026-05-07 | $5.92M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$224.00K derived: sum of 2 quarters · filed 2026-02-26 | $767.00K derived: sum of 3 quarters · filed 2026-02-26 | $3.03M 10-K · filed 2026-02-26 |
| 2025-10-03 | -$1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$399.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.86M 10-Q · filed 2025-11-06 | $5.25M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-07-04 | $991.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.25M 10-Q · filed 2025-08-07 | $6.64M derived: sum of 3 quarters · filed 2025-08-07 | $10.50M derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-04-04 | $2.26M 10-Q · filed 2025-05-08 | $5.65M derived: sum of 2 quarters · filed 2025-05-08 | $9.51M derived: sum of 3 quarters · filed 2025-05-08 | $11.75M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $7.24M derived: sum of 2 quarters · filed 2025-02-26 | $9.49M derived: sum of 3 quarters · filed 2025-02-26 | $10.62M 10-K · filed 2025-02-26 |
| 2024-09-27 | $3.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $6.10M derived: sum of 2 quarters · filed 2024-11-06 | $7.23M 10-Q · filed 2024-11-06 | -$877.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-28 | $2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $3.37M 10-Q · filed 2024-08-07 | -$4.73M derived: sum of 3 quarters · filed 2024-08-07 | -$3.31M derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-29 | $1.13M 10-Q · filed 2024-05-02 | -$6.97M derived: sum of 2 quarters · filed 2024-05-02 | -$5.55M derived: sum of 3 quarters · filed 2024-05-02 | -$4.23M derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | -$8.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$6.68M derived: sum of 2 quarters · filed 2024-02-22 | -$5.36M derived: sum of 3 quarters · filed 2024-02-22 | -$4.84M 10-K · filed 2024-02-22 |
| 2023-09-29 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.74M derived: sum of 2 quarters · filed 2023-11-07 | $3.27M 10-Q · filed 2023-11-07 | $2.48M derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.84M 10-Q · filed 2023-08-03 | $1.05M derived: sum of 3 quarters · filed 2023-08-03 | $4.05M derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | $528.00K 10-Q · filed 2023-05-04 | -$265.00K derived: sum of 2 quarters · filed 2023-05-04 | $2.74M derived: sum of 3 quarters · filed 2023-05-04 | -$2.13M derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | -$793.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.21M derived: sum of 2 quarters · filed 2023-03-01 | -$2.65M derived: sum of 3 quarters · filed 2023-03-01 | $2.55M 10-K · filed 2023-03-01 |
| 2022-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$1.86M derived: sum of 2 quarters · filed 2022-11-02 | $3.35M 10-Q · filed 2022-11-02 | $5.91M derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-07-01 | -$4.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $343.00K 10-Q · filed 2022-08-04 | $2.91M derived: sum of 3 quarters · filed 2022-08-04 | $2.31M derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-04-01 | $5.21M 10-Q · filed 2022-05-10 | $7.77M derived: sum of 2 quarters · filed 2022-05-10 | $7.17M derived: sum of 3 quarters · filed 2022-05-10 | $7.51M derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $1.97M derived: sum of 2 quarters · filed 2022-02-22 | $2.31M derived: sum of 3 quarters · filed 2022-02-22 | $2.55M 10-K · filed 2022-02-22 |
| 2021-10-01 | -$596.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$256.00K derived: sum of 2 quarters · filed 2021-11-04 | -$17.00K 10-Q · filed 2021-11-04 | $2.46M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-07-02 | $340.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $579.00K 10-Q · filed 2021-07-28 | $3.05M derived: sum of 3 quarters · filed 2021-07-28 | $8.29M derived: sum of 4 quarters · filed 2021-07-28 |
| 2021-04-02 | $239.00K 10-Q · filed 2021-04-29 | $2.71M derived: sum of 2 quarters · filed 2021-04-29 | $7.95M derived: sum of 3 quarters · filed 2021-04-29 | $8.46M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $7.71M derived: sum of 2 quarters · filed 2021-02-18 | $8.23M derived: sum of 3 quarters · filed 2021-02-18 | $7.57M 10-K · filed 2021-02-18 |
| 2020-10-02 | $5.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $5.75M derived: sum of 2 quarters · filed 2020-10-29 | $5.10M 10-Q · filed 2020-10-29 | |
| 2020-07-03 | $511.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$141.00K 10-Q · filed 2020-08-06 | ||
| 2020-04-03 | -$652.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |